[The correction of a secondary immunological deficit caused by the Coxsackie B3 virus by using an immunomodulator of bacterial origin].
Semenova
I B
IB
Vasil'eva
I G
IG
Akatov
A K
AK
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D003384:Coxsackievirus Infections / Q000150:complications / Q000188:drug therapy*; D004353:Drug Evaluation, Preclinical; D029822:Enterovirus B, Human; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000209:etiology; D051379:Mice; D008807:Mice, Inbred BALB C; D013208:Staphylococcal Toxoid / Q000627:therapeutic use*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D013208:Staphylococcal Toxoid
Korrektsiia vtorichnogo immunologicheskogo defitsita, vyzvannogo virusom Koksaki B3, s pomoshch'iu immunomoduliatora bakterial'nogo proiskhozhdeniia.